Results date: – 13 March 2015:
Oxford, UK – 6 March 2015: Oxford BioMedica plc (LSE: OXB), (“OXB” or “the Company”) a leading gene and cell therapy company, will be announcing its preliminary results for the twelve months ended 31 December 2014 on Friday 13 March 2015.
An analyst briefing will be held at 9am GMT on 13 March 2015 at the offices of Consilium Strategic Communications: 41 Lothbury, EC2R 7HG. An audio replay will be made available shortly after the presentation on the Company’s website: www.oxfordbiomedica.co.uk.
-Ends-